PacBio · 1 day ago
Scientist II, Bioinformatics
PacBio is a premier life science technology company that designs and manufactures advanced sequencing solutions. The role involves developing and applying long-read sequencing methods in cancer research and human genomics, building software for streamlined analysis of genomic data, and collaborating with both internal teams and external partners.
BiotechnologyChemicalGeneticsLife ScienceMedical
Responsibilities
Build reliable, well-tested bioinformatic software and end-to-end analysis pipelines
Apply bioinformatic tools to answer biological questions related to human health, including cancer and rare disease
Collaborate with external partners in both academia and industry, supporting and leading projects
Benchmark and evaluate bioinformatic methods
Communicate scientific findings through oral and written formats, including papers, posters, and talks at national and international scientific conferences
Qualification
Required
Ph.D. in a computational or biological field (e.g., bioinformatics, genetics, genomics, computer science)
Strong programming skills in Rust, Python, or C++
Proficiency in analyzing large-scale sequencing datasets (e.g., genomics, transcriptomics, epigenomics, genome assemblies)
Foundational understanding of cancer genetics, human genomics, or RNA biology, with interest in developing deep expertise in these areas
Basic statistical skills for analyzing large datasets, including visualization, modeling, and quality control
Track record of scientific publishing, including first-author manuscripts
Excellent interpersonal, written, and verbal communication skills
Preferred
Experience working within large scientific consortia and collaborating closely with both wet-lab and computational teams
Demonstrated ability to develop and maintain analysis pipelines using WDL or Snakemake
Experience building and deploying containerized software (e.g., Docker or Singularity)
Familiarity with modern software development practices
Company
PacBio
PacBio is a biotechnology company that designs, develops, and manufactures sequencing systems.
Funding
Current Stage
Public CompanyTotal Funding
$1.96BKey Investors
SoftBankDeerfieldMaverick Ventures
2023-08-17Post Ipo Equity· $85M
2023-06-23Post Ipo Debt· $441M
2023-01-24Post Ipo Equity· $175M
Recent News
2025-11-11
2025-11-11
Company data provided by crunchbase